Since 1910, Abbott has been dedicated to helping people in India live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. Abbott India Limited is a public limited company domiciled and incorporated in India under the provisions of the then Companies Act, 1913. The company is listed and traded on the Bombay Stock Exchange. It is traded on the National Stock Exchange under the ‘permitted category’.

Abbott India, a publicly listed company and a subsidiary of Abbott Laboratories, takes pride in offering high-quality trusted medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

One of India's fastest-growing pharmaceutical companies, Abbott India Limited is part of Abbott's global pharmaceutical business in India. It has expertise across product development, manufacturing, sales and customer service and dedicated to providing high-quality, reliable products with the expert clinical support customers need.

Abbott India provides quality healthcare through a mix of global and local products for people in India. Its in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Its employees work to produce high-quality, high-volume formulations using cost efficient processes. And, its trained personnel are dedicated to ensuring compliance with international quality standards.

Business area of the company

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.

Abbott India Ltd.

Zydus Lifesciences Ltd.

Alkem Laboratories Ltd.

Lupin Ltd.

Biocon Ltd.

Torrent Pharmaceuticals Ltd.

Gland Pharma Ltd.

Aurobindo Pharma Ltd.

Laurus Labs Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Ipca Laboratories Ltd.

Pfizer Ltd.

Piramal Enterprises Ltd.

Ajanta Pharma Ltd.

JB Chemicals & Pharmaceuticals Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	42,911 Cr		EPS	415.0		High	20550
Stock P/E	48.7		Net Profit Margin	NA		Low	20100

Open Price	20182.9	Volume	2
Prev. Close	20182.9

ABBOTINDIA